Main > ONCOLOGY (**) > Bladder Cancer>mUC *** > Treatment > DE. M. AveluMAb **



DE. M. AveluMAb **'s subsections
(*) EU Approval Date: 2021. 01.25
(*) USA Approval Date: 2017. 05.09.
Company
Human Anti-PD-L1 AB
Partner
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 09.29.
TradeMark
TradeMark Web-Site

DE. M. AveluMAb **'s products
This section has no products